Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Human Reproduction (Oxford, England)|September 2, 2022
17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeaeSeung Gee Lee, Wongsakorn Kiattiburut, Thitiporn Khongkha, et al.
British Journal of Clinical Pharmacology|June 13, 2022
Population pharmacokinetics of cabotegravir following administration of oral tablet and long-acting intramuscular injection in adult HIV-1-infected and uninfected subjectsKelong Han, Mark Baker, Mark Lovern, et al.
HIV Medicine|November 22, 2022
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trialsParul Patel, Susan L Ford, Mark Baker, et al.
Clinical and Translational Medicine|June 18, 2024
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenomaQin Xu, Ting La, Kaihong Ye, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug DevelopmentJames S McCarthy, Louise Marquart, Silvana Sekuloski, et al.
Clinical Pharmacokinetics|August 21, 2023
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and AdolescentsHardik Chandasana, Mita Thapar, Siobhan Hayes, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2025
SNORD80-guided 2'-O-methylation stabilizes the lncRNA GAS5 to regulate cellular stress responsesLiang Xu, Xiao Hong Zhao, Yuan Yuan Zhang, et al.
Complex Psychiatry|August 26, 2022
Neuropsychiatric Genetics of Psychosis in the Mexican Population: A Genome-Wide Association Study Protocol for Schizophrenia, Schizoaffective, and Bipolar Disorder Patients and ControlsBeatriz Camarena, Elizabeth G Atkinson, Mark Baker, et al.
The Lancet. Infectious Diseases|June 18, 2018
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a studyAlejandro Llanos-Cuentas, Martin Casapia, Raúl Chuquiyauri, et al.
AIDS (London, England)|March 17, 2021
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysisAmy G Cutrell, Jonathan M Schapiro, Carlo F Perno, et al.
Pageof 19